SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-23-021613
Filing Date
2023-02-14
Accepted
2023-02-14 16:08:46
Documents
1
Group Members
DAN ORENDEXXON HOLDINGS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236181-1_sc13ga.htm SC 13G/A 68933
  Complete submission text file 0001104659-23-021613.txt   70463
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 23629161
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Filed by) CIK: 0001720007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A